Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

245.11
Delayed Data
As of Feb 11
 -7.09 / -2.81%
Today’s Change
243.03
Today|||52-Week Range
480.18
-19.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues5.5B6.9B9.7B10.8B
 
 
 
 
 
Cost of Goods Sold382.1M668.9M972.6M1.2B
 
 
 
 
 
Depreciation And Amortization365.6M531.7M637.3M--
 
 
 
 
 
Operating ExpensesGross Income4.7B5.7B8.1B9.5B
 
 
 
 
 
General Expenses2.6B3.2B4.1B4.1B
 
 
 
 
 
Other Operating Expenses317.9M0.000.00382.6M
 
 
 
Research And Development1.3B1.4B1.9B2.0B
 
 
 
 
 
Total Operating Expenses3.7B4.4B5.7B5.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.8B2.5B4.0B5.0B
 
 
 
 
 
Extraordinary Credit400.0K5.7M38.9M--
 
 
 
 
Extraordinary Charge-34.9M-2.8M-67.9M-123.9M
 
 
 
 
 
Interest Expense On Debt69.6M39.7M35.9M--
 
 
 
 
Equity In Earnings-4.5M-17.2M-15.1M12.5M
 
 
 
 
 
Other Expenses93.2M-1.9M32.1M-123.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.9B2.5B3.9B4.8B
 
 
 
 
 
Income Taxes-470.6M-601.0M-989.9M-1.2B
 
 
 
 
 
Minority Interest0.000.00-6.8M-46.2M
 
 
 
Net Income1.4B1.9B2.9B3.5B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS237.9M236.9M236.4M230.7M
 
 
 
 
 
Shares To Calculate EPS Diluted239.7M238.3M237.2M231.2M
 
 
 
 
 
 
Earnings Per ShareEPS$5.76$7.81$12.37$15.34
 
 
 
 
 
EPS Diluted$5.76$7.81$12.37$15.34